Author/year | Number of patients | 30-Day mortality | Cause of death | Follow-up | Long-term survival |
Bolman [4] /1984 | 14 | 14% | 1) Graft failure. 2) Arrhythmia | Mean 31 months | 78.6% at 31 months |
Dresler [5] /1997 | 45 | 8.8% | 1) sepsis 2) GI complication 3) Cardiogenic | Mean 44 month | 1-year: 88% 5-years: 85% |
Mitruka [6] /1997 | 64 patients with ASOT ( 62.5% were kidney transplants) | 3% | 1) Sepsis 2) Arrhythmia | Mean 23 months | 2-years: 80%. |
Ferguson [7] /1999 | 45 patients (CABG only) | 7% | Cardiogenic | Median 65.9 months | 1 year: 93% 5-years: 59.5% 10-years: 30% |
Ono [8] /2002 | 60 ASOT patients (77% were kidney transplants) | 5% | 1) Cardiogenic 2) Neurological | Mean 38.7 months | 3-years: 71% 5-years: 67% |
Reddy [9] /2002 | 26 | 7.7% | 1. GI complication 2.PE | Mean 38 months | 69% |
Herzog [10] /2004 | 2661 (only CABG patients) | CABG no IMA 9.4% CABG with IMA 5% | Not reported | Mean 25 months | 2-years survival was 74% (no IMA) and 83% (with IMA) |
Massad [11] /2005 | 32 (only CABG) | 6.2% | Cardiogenic | Mean 63 months | 1-year: 92% 3-years: 87% 5-years: 79% |
Moazami [12] /2006 | 26 | Zero | No death | Not reported | 3-year: 69% |
Zhang [13] /2006 | 57 | 5.3% | Cardiogenic | Median 34 months | 3-year: 71% |
Deb [14] /2006 | 47 ASOT patients (72% were kidney transplants) | 2 % | Cardiogenic | Mean 39 months | 1-year: 97% 5-years: 82% |
John [15] /2007 | 70 ASOT patients (83% were kidney transplants) | 1.4% | Neurological | Mean 1 month | Not reported |
Musci [16] /2007 | 39 patients with kidney or heart transplants (41% were kidney transplants) | 18.8% kidney transplant | Sepsis | Mean 39 months | 3-years: 81.3% |
Rahmanian [17] /2009 | 29 | 3.4% | Sepsis | Mean 2.6 years | 1 year: 89% 5-years: 50% |
Sharma A [18] /2010 | 1335 (only valve surgery) | 14% | 1) Cardiogenic 2) Sepsis | Mean 34.4 months | 1 year: 70.8% 5-years 38.4% 10-years: 16% |
Shayan [19] /2011 | 43 (CABG only) | 7% | 1) Cardiogenic 2) GI complication 3) Sepsis | Mean 4.3 years | 1 year: 76% 5-years: 61% 8-years: 32% |
Sharma R [20] /2012 | 36 kidney and liver transplants (30 were kidney transplants) | ZERO | No death | Mean 4 years | 1 year: 94% 5-years: 80% 10 years: 59% |
Lenihan [21] /2013 | 1594 (CABG only) | 5% | 1) Cardiogenic 2) Sepsis | Median 3.6 years for CABG patients | 2-years survival 76% 5-years survival 55% |
Rocha [22] /2014 | 92 | 11% | 1) Cardiogenic 2) Sepsis 3) GI complication | Mean 4.2 years | 1-year survival 72% 5-year survival 47% 8-year survival 30% |
Vargo [23] /2015 | 3535 ASOT patients (77% were kidney transplants) | 7% | Not reported | Not reported | No long term follow-up |
Basic-Jukic [24] /2015 | 13 | 15% | Not reported | No follow-up | No long term follow-up |
Tooley [25] /2016 | 2146 (CABG only) | 2.7% | Not reported | No follow-up | No long term follow-up. |
Farag [26] /2017 | 70 ASOT patients (70% were kidney transplants) | 12.2% kidney transplant. | 1) Sepsis 2) Cardiogenic | Median 32 months | 1-year: 74% 5-years 66% 10-years: 56% |
Kohmoto [27] /2018 | 115 ASOT patients (71% were kidney transplants) | 4% kidney transplant. | 1) Cardiogenic 2) Sepsis 3) GI complication | Median 39 months | 3-years: 60% 5-Years: 31% 10-years: 12% |
Bozso [28] /2019 | 20 patients with kidney, liver, lung, bone-marrow. (70% were Kidney transplants) | Zero | No death. | Median 3.9 years | 2-years: 66% 5-years: 50% 10-years: 50% |
Komagamine [29] /2020 | 23 | 4.3% | Sepsis | Mean 78 months | 1-year 95.7% 5-years 95.7% 10-years: 58.2% |
Mace [30] /2020 | 179 | 6% | Not reported | Mean 1 year | 1-year: 82.4% |
Bianco [31] /2020 | 129 ASOT (65% were Kidney transplants) | 2% | Not reported | Mean 5 years | 5-years: 75% |
Fabio [32] /2021 | 129 ASOT patients (76% were kidney transplants). Only valve surgery. | 14% | 1) Sepsis 2) Cardiogenic | Median 51 months | 5-years: 59% 10-years: 47% 15-years:40% |
Fazmin [33] /2021 | 38 | 15.8% | Not reported | Not reported | 1-year: 79% 5-year: 63% |